Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative Colitis

Kasugai-shi

Nagoya

Toyota-shi

Hirosaki-shi

Sakura-shi

Matsuyama

Fukui-shi

Chikushino-shi

Fukuoka

Kitakyushu-shi

Kurume-shi

Fukuyama-shi

Hatsukaichi-shi

Hiroshima

Asahikawa-shi

Hakodate-shi

Sapporo

Tomakomai-shi

Akashi-shi

Himeji-shi

Itami-shi

Kobe

Nishinomiya-shi

Komatsu-shi

Marukame-shi

Takamatsu

Kagoshima

Fujisawa-shi

Kamakura-shi

Kawasaki-shi

Sagamihara-shi

Yokohama

Kochi

Kumamoto

Kyoto

Sendai

Nagasaki

Beppu-shi

Ōita

Okayama

Moriguchi-shi

Osaka

Sakai-shi

Suita-shi

Saga

Tokorozawa-shi

Ōtsu

Hamamatsu

Shimotsuke-shi

Adachi-ku

Bunkyo-ku

Chiyoda-ku

Edogawa City

Minato-ku

Shinagawa-ku

Shinjuku-ku

Wakayama

Shunan-shi

Kofu